{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:46:43Z","timestamp":1768834003754,"version":"3.49.0"},"reference-count":170,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatic fibrosis has been associated with a series of pathophysiological processes causing excessive accumulation of extracellular matrix proteins. Several cellular processes and molecular mechanisms have been implicated in the diseased liver that augments fibrogenesis, fibrogenic cytokines and associated liver complications. Liver biopsy remains an essential diagnostic tool for histological evaluation of hepatic fibrosis to establish a prognosis. In addition to being invasive, this methodology presents with several limitations including poor cost-effectiveness, prolonged hospitalizations, and risks of peritoneal bleeding, while the clinical use of this method does not reveal underlying pathogenic mechanisms. Several alternate noninvasive diagnostic strategies have been developed, to determine the extent of hepatic fibrosis, including the use of direct and indirect biomarkers. Immediate diagnosis of hepatic fibrosis by noninvasive means would be more palatable than a biopsy and could assist clinicians in taking early interventions timely, avoiding fatal complications, and improving prognosis. Therefore, we sought to review some common biomarkers of liver fibrosis along with some emerging candidates, including the oxidative stress-mediated biomarkers, epigenetic and genetic markers, exosomes, and miRNAs that needs further evaluation and would have better sensitivity and specificity. We also aim to elucidate the potential role of cardiotonic steroids (CTS) and evaluate the pro-inflammatory and profibrotic effects of CTS in exacerbating hepatic fibrosis. By understanding the underlying pathogenic processes, the efficacy of these biomarkers could allow for early diagnosis and treatment of hepatic fibrosis in chronic liver diseases, once validated.<\/jats:p>","DOI":"10.3390\/ijms21134737","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T06:51:20Z","timestamp":1593759080000},"page":"4737","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis"],"prefix":"10.3390","volume":"21","author":[{"given":"Mishghan","family":"Zehra","sequence":"first","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Curry","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha S.","family":"Pillai","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari Vishal","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory E.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1179-2985","authenticated-orcid":false,"given":"Komal","family":"Sodhi","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Sciences, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Weiskirchen, R., Weiskirchen, S., and Tacke, F. (2018). Recent advances in understanding liver fibrosis: Bridging basic science and individualized treatment concepts. F1000Res, 7.","DOI":"10.12688\/f1000research.14841.1"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"AbdulHameed, M.D., Tawa, G.J., Kumar, K., Ippolito, D.L., Lewis, J.A., Stallings, J.D., and Wallqvist, A. (2014). Systems level analysis and identification of pathways and networks associated with liver fibrosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112193"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.2174\/092986712803341520","article-title":"Role of oxidative stress and molecular changes in liver fibrosis: A review","volume":"19","author":"Uribe","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cld.2008.07.005","article-title":"Oxidative and nitrosative stress and fibrogenic response","volume":"12","author":"Urtasun","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms12042434","article-title":"Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells","volume":"12","author":"Li","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4137\/BMI.S10009","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"Liu","year":"2012","journal-title":"Biomark Insights"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","article-title":"Pathogenesis of liver fibrosis: Role of oxidative stress","volume":"21","author":"Poli","year":"2000","journal-title":"Mol. Aspects Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: A translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41598-020-60615-0","article-title":"Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis","volume":"10","author":"Hoffmann","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.11622\/smedj.2018145","article-title":"A practical clinical approach to liver fibrosis","volume":"59","author":"Kumar","year":"2018","journal-title":"Singapore Med. J."},{"key":"ref_13","first-page":"737","article-title":"Reversibility of liver fibrosis","volume":"9","author":"Brenner","year":"2013","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02899424","article-title":"Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells","volume":"59","author":"Ramadori","year":"1990","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.cgh.2015.08.015","article-title":"Current and Future Burden of Chronic Nonmalignant Liver Disease","volume":"13","author":"Udompap","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pathophys.2008.05.001","article-title":"The role of adipokines in liver fibrosis","volume":"15","author":"Bertolani","year":"2008","journal-title":"Pathophysiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1748-0361.2012.00422.x","article-title":"The metabolic syndrome: Are rural residents at increased risk?","volume":"29","author":"Trivedi","year":"2013","journal-title":"J. Rural. Health"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sharma, D.L., Lakhani, H.V., Klug, R.L., Snoad, B., El-Hamdani, R., Shapiro, J.I., and Sodhi, K. (2017). Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis. J. Clin. Cell Immunol., 8.","DOI":"10.4172\/2155-9899.1000523"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pacheco, L.S., Hernandez-Ontiveros, D.A., Iniguez-Stevens, E., Brodine, S., Garfein, R.S., Santibanez, M., and Fraga, M.A. (2018). Prevalence and correlates of diabetes and metabolic syndrome in a rural indigenous community in Baja California, Mexico. BMC Public Health, 18.","DOI":"10.1186\/s12889-018-6276-x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"FSO250","DOI":"10.4155\/fsoa-2017-0083","article-title":"Liver fibrosis: A compilation on the biomarkers status and their significance during disease progression","volume":"4","author":"Nallagangula","year":"2018","journal-title":"Future Sci. OA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphar.2016.00159","article-title":"Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?","volume":"7","author":"Chin","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_24","first-page":"187","article-title":"Biomarkers for liver fibrosis: Advances, advantages and disadvantages","volume":"79","author":"Cequera","year":"2014","journal-title":"Rev. Gastroenterol. Mex."},{"key":"ref_25","first-page":"149","article-title":"Noninvasive biochemical markers of liver fibrosis","volume":"15","author":"Grigorescu","year":"2006","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/liv.14390","article-title":"Collagen biology and non-invasive biomarkers of liver fibrosis","volume":"40","author":"Karsdal","year":"2020","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"Armstrong","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The Role of Oxidative Stress and Antioxidants in Liver Diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_30","first-page":"160","article-title":"Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside","volume":"15","author":"Arauz","year":"2016","journal-title":"Ann. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20111451","article-title":"Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling","volume":"441","author":"Lee","year":"2012","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Michalak","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.redox.2015.07.005","article-title":"Role of NADPH oxidases in the redox biology of liver fibrosis","volume":"6","author":"Fabregat","year":"2015","journal-title":"Redox Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.72.4.2123-2130.2004","article-title":"Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression","volume":"72","author":"Ryan","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_37","first-page":"69","article-title":"The NF-kappaB-mediated control of ROS and JNK signaling","volume":"21","author":"Bubici","year":"2006","journal-title":"Histol. Histopathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1755-1536-5-S1-S4","article-title":"The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis","volume":"5","author":"Novo","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cld.555","article-title":"Biomarkers of liver fibrosis","volume":"7","author":"Morling","year":"2016","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jhbp.333","article-title":"Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: A follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease","volume":"23","author":"Yamamoto","year":"2016","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1440-1746.1995.tb01798.x","article-title":"Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis","volume":"10","author":"Tsukamoto","year":"1995","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.3748\/wjg.v25.i33.4835","article-title":"Crosstalk network among multiple inflammatory mediators in liver fibrosis","volume":"25","author":"Zhangdi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1186\/1755-1536-5-S1-S27","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: Functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"ref_48","first-page":"361","article-title":"Molecular pathogenesis of liver fibrosis","volume":"120","author":"Brenner","year":"2009","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_51","first-page":"943497","article-title":"Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response","volume":"2015","author":"Duval","year":"2015","journal-title":"Int. J. Inflam."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: Mechanisms of immune-mediated liver injury","volume":"9","author":"Xu","year":"2012","journal-title":"Cell Mol. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: Therapeutic strategies","volume":"10","author":"Gallego","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cld.2008.07.012","article-title":"Genetic determinants in hepatic fibrosis: From experimental models to fibrogenic gene signatures in humans","volume":"12","author":"Weber","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrgastro.2010.170","article-title":"Genome-wide association studies and genetic risk assessment of liver diseases","volume":"7","author":"Krawczyk","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng1599","article-title":"Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans","volume":"37","author":"Hillebrandt","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhep.2007.09.008","article-title":"The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection","volume":"48","author":"Wasmuth","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2010.10.042","article-title":"Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease","volume":"55","author":"Krawczyk","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hall, R.A., Liebe, R., Hochrath, K., Kazakov, A., Alberts, R., Laufs, U., Bohm, M., Fischer, H.P., Williams, R.W., and Schughart, K. (2014). Systems genetics of liver fibrosis: Identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089279"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/gast.2002.37069","article-title":"Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15","volume":"123","author":"Hillebrandt","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/jir424","article-title":"CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C","volume":"204","author":"Zeremski","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40169-017-0156-3","article-title":"CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: A cross-sectional study","volume":"6","author":"Medrano","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and Liver Fibrosis","volume":"4","author":"Mann","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1620\/tjem.229.35","article-title":"Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis","volume":"229","author":"Zhao","year":"2013","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: A new source of biomarkers","volume":"717","author":"Etheridge","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","article-title":"MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1","volume":"21","author":"Yan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","article-title":"Epigenetic regulation of miR-34a expression in alcoholic liver injury","volume":"181","author":"Meng","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18066","DOI":"10.1074\/jbc.M110.196451","article-title":"Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122","volume":"286","author":"Boutz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"Trebicka","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGFbeta-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00705-015-2474-3","article-title":"Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7","volume":"160","author":"Zhu","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/jcp.22598","article-title":"Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation","volume":"226","author":"Sekiya","year":"2011","journal-title":"J. Cell Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-013-1895-0","article-title":"Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation","volume":"388","author":"Sun","year":"2014","journal-title":"Mol. Cell Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Roderburg, C., Mollnow, T., Bongaerts, B., Elfimova, N., Vargas Cardenas, D., Berger, K., Zimmermann, H., Koch, A., Vucur, M., and Luedde, M. (2012). Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032999"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/hep4.1290","article-title":"Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis","volume":"3","author":"Chen","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","article-title":"Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials","volume":"1820","author":"Vlassov","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.23574","article-title":"Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury","volume":"51","author":"Wetmore","year":"2010","journal-title":"Hepatology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.200900103","article-title":"Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples","volume":"4","author":"Gonzalez","year":"2010","journal-title":"Proteomics Clin. Appl."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fphar.2017.00748","article-title":"The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis","volume":"8","author":"Alhomrani","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.28644","article-title":"Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by gammadelta T cells in liver fibrosis","volume":"64","author":"Seo","year":"2016","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.26768","article-title":"Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1021\/pr8004887","article-title":"Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes","volume":"7","author":"Embade","year":"2008","journal-title":"J. Proteome Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.surg.2014.04.014","article-title":"Exosomes mediate intercellular transfer of pro-fibrogenic connective tissue growth factor (CCN2) between hepatic stellate cells, the principal fibrotic cells in the liver","volume":"156","author":"Charrier","year":"2014","journal-title":"Surgery"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Welker, M.W., Reichert, D., Susser, S., Sarrazin, C., Martinez, Y., Herrmann, E., Zeuzem, S., Piiper, A., and Kronenberger, B. (2012). Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030796"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Khalaf, F.K., Dube, P., Mohamed, A., Tian, J., Malhotra, D., Haller, S.T., and Kennedy, D.J. (2018). Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na(+)\/K(+)-ATPase. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092576"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/CIRCHEARTFAILURE.114.001976","article-title":"Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure","volume":"8","author":"Kennedy","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000363301","article-title":"The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease","volume":"128","author":"Pavlovic","year":"2014","journal-title":"Nephron. Clin. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.bbadis.2010.01.013","article-title":"The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking","volume":"1802","author":"Liu","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/ndt\/gfn325","article-title":"Role of endogenous cardiotonic steroids in sodium homeostasis","volume":"23","author":"Schoner","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"C509","DOI":"10.1152\/ajpcell.00098.2007","article-title":"Endogenous and exogenous cardiac glycosides: Their roles in hypertension, salt metabolism, and cell growth","volume":"293","author":"Schoner","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"F1219","DOI":"10.1152\/ajprenal.90710.2008","article-title":"Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: Implications for uremic cardiomyopathy","volume":"296","author":"Elkareh","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"F922","DOI":"10.1152\/ajprenal.90605.2008","article-title":"The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: Implication of epithelial-to-mesenchymal transition","volume":"296","author":"Fedorova","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/pr.108.000711","article-title":"Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets","volume":"61","author":"Bagrov","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/HJH.0b013e32831cf2c6","article-title":"Endogenous ouabain in cardiovascular function and disease","volume":"27","author":"Manunta","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kennedy, D.J., Khalaf, F.K., Sheehy, B., Weber, M.E., Agatisa-Boyle, B., Conic, J., Hauser, K., Medert, C.M., Westfall, K., and Bucur, P. (2018). Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na(+)\/K(+)-ATPase Profibrotic Signaling Pathways. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092566"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.HYP.0000252409.36927.05","article-title":"Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy","volume":"49","author":"Elkareh","year":"2007","journal-title":"Hypertension"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/ndt\/gfq772","article-title":"Endogenous cardiotonic steroids in chronic renal failure","volume":"26","author":"Kolmakova","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1152\/japplphysiol.00119.2008","article-title":"Effects of cardiotonic steroids on dermal collagen synthesis and wound healing","volume":"105","author":"Smaili","year":"2008","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/FJC.0000000000000730","article-title":"Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats","volume":"74","author":"Fedorova","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"27838","DOI":"10.1074\/jbc.M002950200","article-title":"Ouabain interaction with cardiac Na+\/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Haller, S.T., Yan, Y., Drummond, C.A., Xie, J., Tian, J., Kennedy, D.J., Shilova, V.Y., Xie, Z., Liu, J., and Cooper, C.J. (2016). Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling. J. Am. Heart Assoc., 5.","DOI":"10.1161\/JAHA.116.004106"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00018-009-9018-5","article-title":"Digoxin and ouabain increase the synthesis of cholesterol in human liver cells","volume":"66","author":"Campia","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/BJ20120200","article-title":"Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes","volume":"447","author":"Campia","year":"2012","journal-title":"Biochem. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jsbmb.2005.08.004","article-title":"Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments","volume":"97","author":"Pasqualini","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2548154","DOI":"10.1155\/2018\/2548154","article-title":"Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression","volume":"2018","author":"Tirosh","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"102156","DOI":"10.1016\/j.ceca.2019.102156","article-title":"Endogenous cardiotonic steroids and cardiovascular disease, where to next?","volume":"86","author":"Pavlovic","year":"2020","journal-title":"Cell Calcium"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1006\/bbrc.1995.1996","article-title":"Secretion of endogenous ouabain from bovine adrenocortical cells: Role of the zona glomerulosa and zona fasciculata","volume":"212","author":"Laredo","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4254\/wjh.v4.i6.184","article-title":"Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic \u201cpower station\u201d","volume":"4","author":"Trapani","year":"2012","journal-title":"World J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcell.2018.00150","article-title":"Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis","volume":"6","author":"Hou","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2011.11.004","article-title":"Lipids in liver disease: Looking beyond steatosis","volume":"142","author":"Schwabe","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","article-title":"Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells","volume":"61","author":"Tomita","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hepr.13040","article-title":"Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis","volume":"48","author":"Furuhashi","year":"2018","journal-title":"Hepatol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"J. Inflamm. (Lond)"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/labinvest.2015.67","article-title":"The role of iNOS in cholesterol-induced liver fibrosis","volume":"95","author":"Anavi","year":"2015","journal-title":"Lab. Invest."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Pratt, R.D., Brickman, C.R., Cottrill, C.L., Shapiro, J.I., and Liu, J. (2018). The Na\/K-ATPase Signaling: From Specific Ligands to General Reactive Oxygen Species. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092600"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MJT.0b013e318217a609","article-title":"On the differences between ouabain and digitalis glycosides","volume":"21","author":"Fuerstenwerth","year":"2014","journal-title":"Am. J. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.1422997112","article-title":"Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex","volume":"112","author":"Laursen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-291X(03)00922-7","article-title":"Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA","volume":"306","author":"Takara","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0032-1328243","article-title":"Cardiotonic steroids-mediated Na+\/K+-ATPase targeting could circumvent various chemoresistance pathways","volume":"79","author":"Mijatovic","year":"2013","journal-title":"Planta. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcp.20415","article-title":"Inhibitory effects of digoxin and ouabain on aldosterone synthesis in human adrenocortical NCI-H295 cells","volume":"205","author":"Kau","year":"2005","journal-title":"J. Cell Physiol."},{"key":"ref_130","first-page":"315","article-title":"Ouabain chronic infusion enhances the growth and steroidogenic capacity of rat adrenal zona glomerulosa: The possible involvement of the endothelin system","volume":"18","author":"Neri","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcb.20603","article-title":"Mechanisms of digoxin and digitoxin on the production of corticosterone in zona fasciculata-reticularis cells of ovariectomized rats","volume":"97","author":"Pu","year":"2006","journal-title":"J. Cell Biochem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The Role of Cholesterol in the Pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.freeradbiomed.2014.10.594","article-title":"Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease","volume":"75","author":"Bellanti","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"G376","DOI":"10.1152\/ajpgi.00174.2017","article-title":"Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis","volume":"313","author":"Malhotra","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: The emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Mesarwi, O.A., Shin, M.K., Bevans-Fonti, S., Schlesinger, C., Shaw, J., and Polotsky, V.Y. (2016). Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168572"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/jcb.26388","article-title":"Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP\/HIF-1alpha signaling","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08941939.2016.1183734","article-title":"HIF-1 alpha as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats","volume":"30","author":"Moczydlowska","year":"2017","journal-title":"J. Invest. Surg."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.redox.2017.06.008","article-title":"Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers","volume":"13","author":"Anavi","year":"2017","journal-title":"Redox Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: From the bench to clinical targets","volume":"36","author":"Pinzani","year":"2004","journal-title":"Dig. Liver Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario","volume":"29","author":"Parola","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-2-4","article-title":"Hepatic wound repair","volume":"2","author":"Parola","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: One function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_152","first-page":"301","article-title":"Fibroblasts and myofibroblasts in wound healing","volume":"7","author":"Darby","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/0929867324666170619105407","article-title":"Na+,K+-ATPase as a Target for Treatment of Tissue Fibrosis","volume":"26","author":"Orlov","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/path.4116","article-title":"Inflammasomes in wound healing and fibrosis","volume":"229","author":"Artlett","year":"2013","journal-title":"J. Pathol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Friedman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-018-1272-8","article-title":"Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis","volume":"10","author":"George","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41598-017-00306-5","article-title":"pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na\/K-ATPase\/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet","volume":"7","author":"Sodhi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000202594.82271.92","article-title":"Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy","volume":"47","author":"Kennedy","year":"2006","journal-title":"Hypertension"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ajh\/hpt169","article-title":"Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease","volume":"27","author":"Haller","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Paczula, A., Wiecek, A., and Piecha, G. (2019). Cardiotonic Steroids-A Possible Link Between High-Salt Diet and Organ Damage. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030590"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00001","article-title":"Corrigendum: Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain","volume":"9","author":"Lima","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fendo.2014.00097","article-title":"The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na\/K-ATPase Signaling?","volume":"5","author":"Xie","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-physiol-021909-135725","article-title":"The physiological significance of the cardiotonic steroid\/ouabain-binding site of the Na,K-ATPase","volume":"72","author":"Lingrel","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Yan, Y., Shapiro, A.P., Mopidevi, B.R., Chaudhry, M.A., Maxwell, K., Haller, S.T., Drummond, C.A., Kennedy, D.J., Tian, J., and Malhotra, D. (2016). Protein Carbonylation of an Amino Acid Residue of the Na\/K-ATPase alpha1 Subunit Determines Na\/K-ATPase Signaling and Sodium Transport in Renal Proximal Tubular Cells. J. Am. Heart Assoc., 5.","DOI":"10.1161\/JAHA.116.003675"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Cui, X., and Xie, Z. (2017). Protein Interaction and Na\/K-ATPase-Mediated Signal Transduction. Molecules, 22.","DOI":"10.3390\/molecules22060990"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"14881","DOI":"10.1074\/jbc.M109.003574","article-title":"Regulation of intracellular cholesterol distribution by Na\/K-ATPase","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"15517","DOI":"10.1074\/jbc.M110.204396","article-title":"Regulation of alpha1 Na\/K-ATPase expression by cholesterol","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/13\/4737\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:46:44Z","timestamp":1760176004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/13\/4737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":170,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["ijms21134737"],"URL":"https:\/\/doi.org\/10.3390\/ijms21134737","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]}}}